中文簡體ENGLISH

专利领域
PATENT FIELD

杏辉天力拥有强大的研发团队,有14名专业人员,其中包括3名博士、几名高级和初级医学工程师

杏辉天力拥有强大的研发团队,有14名专业人员,其中包括3名博士、几名高级和初级医学工程师。我们拥有的研发团队致力于快速发展的植物提取和分离应用领域,以支持未来的增长。

杏辉天力研发已经与杏辉医药集团的研发中心紧密合作,与中国科学院、北京大学中医药现代研究中心及上海生命科学研究院长期联合开发项目。

与台湾杏辉集团研发中心的信息和人员频繁进行交流, 使杏辉天力研发团队开发了世界领先的标准技术。

我们的研发团队不断的进行探索,不仅在产品开发、生产工艺上的改进以及新技术的引进,同时也对中国法规频繁修改的内容进行审查,对客户提供最新的法律规定。

 

List of Cistanche Tubulosa patents

¤  Patent List

 

No

Title

Country

1.

MEDICINAL PREPARATION CONTAINING PHTNYLETHANOID GLYCOSIDES EXTRACTED FROM HERBACEOUS PLANT, CISTANCHE TUBULOSA(SCHENK.) WIGHT, PROCESS OF MAKING THE SAME, AND USES OF THE SAME

TW,JP,AU,US,CA,DE,FR,IT,CH,ES

2.

NEUROBLAST PROLIFERATE ACCELERANT AND NERVE PROTUBERANCE EXTEND ACCELERANT

TW,CN

3.

Hyperlipemia prophylactic and therapeutic agent

CN

4.

Novel health-care food or drug with function of improving memory

CN

5.

USE OF ISOACTEOSIDE OR PHARAMACEUTICALLY ACCEPABLE SALT THERE OF IN INHIBITING FORMATION, ACCUMULATION OR AGGREGATION OF AMYLOID BETA PEPTIDES, AND IN FABRICATION OF DRUG FOR PREVENTING OR TREATING AMYLOID BETA PEPTIDE-ASSOCIATED DISEASES OR CONDITIONS

TW,JP,SG,MY,AU,CH,DE,FR,GB,BE,CN,US,CA,KR

6.

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AMYLOID BETA PRPTIDE-ASSOCIATED DISEASES OR CONDITIONS

TW,JP,SG,AU,CN,US,CA,KR

7.

ISOACTEOSIDE DERIVATIVE AND USE THREOF

TW

CN,US,KR,EP

8.

METHOD FOR REGULATING BLOOD GLUCOSE LEVEL

TW,CN,JP,RU,US,KR,EP

9.

USES OF CISTANCHE TUBULOSA EXTRACT AND ISOACTEOSIDE IN PROTECTING MUSCLES

US

TW,CN,PCT

10.

METHOD OF USING CISTANCHE TUBULOSA EXTRACT FOR PREPARING DRUGS OR FOOD TO PROTECT EYE CELLS

TW,CN,US,JP,KR,RU,MY,IN,EP

 

Lipucan®

¤  Patent List

 

 

Description

Country

Status

1.Immune Regulation

PHARMACEUTICAL COMPOSITION FOR ENHANCING IMMUNITY, AND EXTRACT OF PORIA

TW

Granted

CN

JP

KR

US

CA

GB

DE

FR

BE

CH

IT

2.Enhance Nutrients Uptake

PHARMACEUTICAL COMPOSITION AND EXTRACT OF PORIA FOR ENHANCING UPTAKE OF NUTRIENTS

TW

Granted

CN

JP

KR

SG

MY

AU

CA

3.Treatment of Immune Disorder

PHARMACEUTICAL COMPOSITION AND EXTRACT OF PORIA FOR TREATING A DISEASE INDUCED FROM IMMUNE DISORDER

TW

Granted

CN

JP

KR

SG

CA

GB

DE

FR

BE

CH

IT

4.Treatment of Carchexia

USE OF LANOSTANE AND PORIA EXTRACT IN TREATING CACHEXIA

TW

Granted

CN

JP

KR

US

GB

CH

IE

DE

5.Treatment of Diabetes

USE OF LANOSTANE AND PORIA EXTRACT IN TREATING DIABETES

TW

Granted

CN

JP

KR

SG

US

GB

DE

FR

IT

6.Treatment of Lung Cancer

K2 COMPOSITION AND THE PREPARATION METHOD AND USE OF THE SAME

TW

Granted

CN

US

JP

Pending

KR

CA

7.Muscle Health Support

USES OF FU-LING (PORIA COCOS) EXTRACT AND TUMULOSIC ACID IN PROTECTING MUSCLES

TW

Pending

CN

US

PCT

8. Respiratory Health Surpport

USES OF FU-LING EXTRACT ON DISEASES CAUSED BY THE DISORDER IN THE ACTIVITY/EXPRESSION OF MMP-9

TW

Pending

CN

US

PCT

 

Prodemax®

¤  Patent List

 

NO.

 

Patent No. and Paper

1

The preparation method and application of Walnut

oligopepide

CN 105567774 A

2

The preparation process and application of Walnut

oligopepide

CN 105936927 A

3

Uses of walnut oligopeptide in anti fatigue

CN 106520872 A

4

Walnut oligopeptide powder, and preparation method and application thereof

PCT/CN2017/000121

5

The high-purity preparation process and application of Walnut oligopepide

CN 107446975 A

6

The walnut oligopeptide's application in anti haze

CN 107439787 A

7

A mixture extracts' preparation method and

application in anti haze

CN 107440114 A

8

Uses of walnut oligopeptide in skin lightener

CN 107365821 A

9

A sample and convenient method for the preparation of antioxidant peptides from walnut (Juglans regia L) protein hydrolysates

Chem Cent J. 2016. 10:39